drugset / Trial / NCT00482898

A Study of MK0359 in Patients With Chronic Asthma (0359-013)

NCT00482898 ↗

Phase 2 Completed 56 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

A study to test the effect of MK0359 in lessening the symptoms of asthma as compared to placebo.

Timeline

Start
2002-09
Primary completion
2003-04
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject MK0359 Unknown — —

Indications